Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Michele Lamuraglia"'
Autor:
Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Most patients with advanced ovarian cancer (AOC) ultimately relapse after platinum-based chemotherapy. Combining bevacizumab, olaparib, and durvalumab likely drives synergistic activity. This open-label phase 2 study (NCT04015739) aimed to a
Externí odkaz:
https://doaj.org/article/afb66d701040478ba283ee012404613d
Autor:
Youssef Elhaitmy, Soukaina El Anssari, Pierre Fournel, Nawfel Mellas, Wafa Bouleftour, Michele Lamuraglia
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Choroidal melanoma (CM) is the most common malignant ocular tumor in adults. The current treatment of metastatic CM is limited by the intrinsic resistance of CM to conventional systemic therapies. Immunotherapy alone or in association with cytotoxic
Externí odkaz:
https://doaj.org/article/c3d4b6b1f0964b67bc10da6129c20af2
Autor:
Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/c7f906a81208468d94569f0e02656fa2
Autor:
Claire Lailler, Michele Lamuraglia, Floriane Racine, Christophe Louandre, Corinne Godin, Bruno Chauffert, Antoine Galmiche, Zuzana Saidak
Publikováno v:
Translational Oncology, Vol 14, Iss 8, Pp 101110- (2021)
Objectives: The immune checkpoint molecule PD-L1 (CD274) is a crucial regulator of the tumor immune response. Its expression has been reported in the therapeutic context in Head and Neck Squamous Cell Carcinoma (HNSCC), but it remains unclear how the
Externí odkaz:
https://doaj.org/article/c882ce83fab946c98b707b15acba5884
Autor:
Michele Lamuraglia MD, PhD, Guillaume Barrois PhD, Delphine Le Guillou-Buffello PhD, Mathieu Santin PhD, Anne Kerbol MD, Eva Comperat MD, Alain Coron PhD, Olivier Lucidarme MD, PhD, S. Lori Bridal PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Background: Association of drugs acting against different antiangiogenic mechanisms may increase therapeutic effect and reduce resistance. Noninvasive monitoring of changes in the antiangiogenic response of individual tumors could guide selection and
Externí odkaz:
https://doaj.org/article/2610f329007a496f912eed53288c2f3f
Autor:
Henri Roché, Jean-Christophe Eymard, Abderraouf Radji, Alain Prevost, Rafik Diab, Michele Lamuraglia, Ravaka-Fatoma Soumoudronga, Isabelle Gasnereau, Alain Toledano
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background The ZOHé study was a prospective, non-interventional, multicentre study in France to assess the use of biosimilar filgrastim Zarzio® (Sandoz filgrastim) in routine clinical practice in patients at risk of neutropenia-inducing ch
Externí odkaz:
https://doaj.org/article/7a9ea4a5e6b04028bb69aa74df0f0d55
Autor:
Olivier Adotévi, Christophe Borg, Eric Tartour, Bernard Maillère, Philippe Saas, Xavier Pivot, Pierre Langlade-Demoyen, Beatrice Gaugler, Françoise Le Pimpec-Barthes, Aurélie Cazes, Nadine Benhamouda, Patrice Ravel, Emeline Levionnois, Michele Lamuraglia, Magalie Dosset, Elizabeth Fabre, Yann Godet
XLS file - 8K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd58eab6c59b93d792befb41273e9d27
https://doi.org/10.1158/1078-0432.22446696.v1
https://doi.org/10.1158/1078-0432.22446696.v1
Autor:
Olivier Adotévi, Christophe Borg, Eric Tartour, Bernard Maillère, Philippe Saas, Xavier Pivot, Pierre Langlade-Demoyen, Beatrice Gaugler, Françoise Le Pimpec-Barthes, Aurélie Cazes, Nadine Benhamouda, Patrice Ravel, Emeline Levionnois, Michele Lamuraglia, Magalie Dosset, Elizabeth Fabre, Yann Godet
PDF file - 60K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af80cc88b4c823954f6ef5668802ccb
https://doi.org/10.1158/1078-0432.22446693.v1
https://doi.org/10.1158/1078-0432.22446693.v1
Autor:
Olivier Adotévi, Christophe Borg, Eric Tartour, Bernard Maillère, Philippe Saas, Xavier Pivot, Pierre Langlade-Demoyen, Beatrice Gaugler, Françoise Le Pimpec-Barthes, Aurélie Cazes, Nadine Benhamouda, Patrice Ravel, Emeline Levionnois, Michele Lamuraglia, Magalie Dosset, Elizabeth Fabre, Yann Godet
Purpose: To investigate the presence and impact of spontaneous telomerase-specific CD4 T-cell responses in cancer patients.Experimental Design: A multistep approach was used to design novel pan-HLA-DR–restricted peptides from telomerase. T-cell clo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c814d81692c30967e79af544cf6c03
https://doi.org/10.1158/1078-0432.c.6520836
https://doi.org/10.1158/1078-0432.c.6520836
Autor:
Chen Zhang, Imene Hadj-Naceur, Julia Matile, Pascal Hammel, Louis de Mestier, Marie-Pauline Gagaille, Jérôme Cros, Elise Colle, Mohamed Bouattour, Michele Lamuraglia
Publikováno v:
Expert Review of Anticancer Therapy
Expert Review of Anticancer Therapy, 2020, 20 (11), pp.939-945. ⟨10.1080/14737140.2020.1820330⟩
Expert Review of Anticancer Therapy, 2020, 20 (11), pp.939-945. ⟨10.1080/14737140.2020.1820330⟩
Tumor control and survival of patients with metastatic pancreatic ductal adenocarcinoma (PDAC) has improved with more effective polychemotherapies. The identification of novel therapeutic targets is strongly needed in order to propose maintenance the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d092e0789eab28725fd6341e5c2a8e10
https://doi.org/10.1080/14737140.2020.1820330
https://doi.org/10.1080/14737140.2020.1820330